Inozyme Pharma to Present at Cowen 42nd Annual Health Care Conference
01.03.2022 - BOSTON, March 01, 2022 (GLOBE NEWSWIRE) - Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced Axel Bolte, MSc, MBA, the ...
Source: wallstreet-online.de